Anuh Pharma Limited (BSE: 506260)
Health Care · Pharmaceuticals · IN
Rs81.57
-6.11% today · -0.9% 1Y
Anuh Pharma Limited (BSE: 506260) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $84.47M.
Over the last twelve months the share price has lost 0.9%, trading between 66.72 and 99.50.
Tweenvest scores Anuh Pharma Limited across four factors: quality 78/100, value 67/100, growth 44/100, dividend 72/100. Its strongest factor is quality.
506260 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $84.47M
- Revenue (TTM)
- $82.39M
- P/E
- 18.52
- EPS
- 4.40
- Dividend yield
- 1.84%
- Beta (5Y)
- 0.48
- 52-week high
- Rs99.50
- 52-week low
- Rs66.72
- Avg volume (3M)
- —
- Shares outstanding
- 100.22M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ahn-Gook Pharmaceutical Co., Ltd.KOSDAQ: A001540 | $85.72M | ₩10,140.00 | +3.36% |
| ECO Animal Health Group plcAIM: EAH | $85.63M | £0.96 | -2.55% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd.TWSE: 1762 | $85.04M | NT$35.35 | +4.74% |
| Protect Animal Health Inc.TPEX: 7850 | $84.75M | NT$27.75 | +13.96% |
| Vistin Pharma ASAOB: VISTN | $83.90M | Nkr18.00 | -0.55% |
| ZIM Laboratories LimitedBSE: 541400 | $83.55M | Rs150.70 | +10.44% |
| Cognition Therapeutics, Inc.NasdaqCM: CGTX | $83.39M | $0.86 | -2.28% |
| Rafael Holdings, Inc.NYSE: RFL | $83.20M | $1.50 | -6.25% |
Figures last refreshed Oct 11, 2026.